5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects*; D001977:Brompheniramine / Q000031:analogs & derivatives / Q000494:pharmacology; D002395:Catecholamines / Q000096:biosynthesis; D003342:Corpus Striatum / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology*; D015031:Zimeldine
D000928:Antidepressive Agents; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D015031:Zimeldine; D001977:Brompheniramine; D000109:Acetylcholine